Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,316 across all filing types
Latest filing 2025-03-12 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Schedule of Analyst/Institutional meet
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of upcoming analyst/institutional investor meetings. It is an intimation under SEBI regulations about investor conference participation. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. The document is brief (1462 characters) and serves as a regulatory announcement rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such miscellaneous regulatory announcements.
2025-03-12 English
FORM 6-K
Regulatory Filings
2025-03-07 English
Intimation of Analyst Meet/Institutional Meet
Regulatory Filings Classification · 95% confidence The document is a letter from Dr. Reddy's Laboratories Ltd. addressed to stock exchanges, informing them about the schedule of upcoming analyst and institutional investor meetings. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about notifying the market and regulators of planned investor meetings, not a financial report, earnings release, or any detailed presentation. The document length is short (1526 characters) and it serves as an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2025-03-07 English
Allotment of Employee stock options
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification from Dr. Reddy's Laboratories Ltd. to multiple stock exchanges about the allotment of equity shares following the exercise of stock options under the company's ESOP scheme. It references compliance with SEBI regulations and provides detailed information about the shares issued, including numbers, dates, and regulatory references. The content is an announcement of a capital change event (allotment of shares due to stock options exercise), not a full financial report or earnings release. The document length is 4274 characters, which is relatively short and focused on a specific event. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2025-03-06 English
6-K Filing
Regulatory Filings
2025-03-06 English
6-K Filing
Regulatory Filings
2025-03-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.